[3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. (Q52453590)

2 May 2018

title

[3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. (English)

1 reference

2 May 2018

author

Joerg Striessnig

2

1 reference

2 May 2018

author name string

A Grassegger

1

1 reference

2 May 2018

M Weiler

3

1 reference

2 May 2018

H G Knaus

4

1 reference

2 May 2018

H Glossmann

5

1 reference

2 May 2018

publication date

1 December 1989

1 reference

2 May 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

2 May 2018

volume

340

1 reference

2 May 2018

issue

6 Pt 2

1 reference

2 May 2018

page(s)

752-759

1 reference

2 May 2018

Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%

cites work

1 reference

12 December 2020

Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves

1 reference

12 December 2020

Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil.

1 reference

12 December 2020

Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.

1 reference

12 December 2020

Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel

1 reference

12 December 2020

1 reference

12 December 2020

Cooperativity in ligand binding: a new graphic analysis

1 reference

12 December 2020

Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations

1 reference

12 December 2020

Assay for calcium channels

1 reference

12 December 2020

Purification and reconstitution of calcium channel drug-receptor sites.

1 reference

12 December 2020

The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

(-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines

1 reference

12 December 2020

Site of covalent attachment of alpha-scorpion toxin derivatives in domain I of the sodium channel alpha subunit

1 reference

12 December 2020

Diversity and novel pharmacological properties of Ca2+ channels in Drosophila brain membranes

1 reference

12 December 2020

Site-site interactions among insulin receptors. Characterization of the negative cooperativity

1 reference

12 December 2020

Calcium antagonist properties of diclofurime isomers. II. Molecular aspects: allosteric interactions with dihydropyridine recognition sites

1 reference

12 December 2020

Structure of calcium channels

1 reference

12 December 2020

(-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle

1 reference

12 December 2020

Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonists

1 reference

12 December 2020

A novel high affinity class of Ca2+ channel blockers

1 reference

12 December 2020

Targets for calcium channel blockers in mammalian skeletal muscle and their respective functions in excitation-contraction coupling

1 reference

12 December 2020

Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle

1 reference

12 December 2020

Calcium channels: basic properties as revealed by radioligand binding studies

1 reference

12 December 2020

Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

1 reference

12 December 2020

Purified calcium channels have three allosterically coupled drug receptors

1 reference

12 December 2020

Structural characterization of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2+ channel from rabbit skeletal muscle. Evidence for two distinct high molecular weight subunits

1 reference

12 December 2020

Identification and affinity labeling of very high affinity binding sites for the phenylalkylamine series of Ca+ channel blockers in the Drosophila nervous system.

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Calcium channel ligands

1 reference

12 December 2020

Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.

1 reference

12 December 2020

(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00169685

0 references

1 reference

2 May 2018